Actively Recruiting
Observational Study of Medication Adherence Using CONNECTDROP4 in Patients with Glaucoma or Ocular Hypertension
Led by Laboratoires Thea · Updated on 2026-08-17
200
Participants Needed
15
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a real-life, national, multicenter, prospective study to observe how well patients with glaucoma or ocular hypertension OHT stick to their eye drop treatment using the connected device CONNECTDROP4. The study aims to measure the average yearly adherence rate, understand each patients adherence pattern, and explore how these adherence profiles relate to clinical data. Participants will use the CONNECTDROP4 device clipped onto an EASYGRIP4 eye drop bottle along with a smartphone app daily. This setup helps track the use of intraocular pressure IOP lowering eye drops over a one-year period. The study does not involve any experimental treatments but focuses on monitoring medication adherence in typical care settings. During the study, participants adherence rates are continuously recorded from the start until 12 months later. Researchers will analyze this data alongside clinical information to assess patterns and associations. The study provides a detailed view of how patients manage their glaucoma or OHT therapy in everyday life, with no intervention beyond regular treatment and device use.
CONDITIONS
Brief Title
Real-world Study to Assess Adherence to IOP Lowering Therapy in Patients With Glaucoma or Ocular Hypertension Using CONNECTDROP®
Research Team
M
Medical Operation Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here